Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Glycopyrrolate 1ml
Generic Name
Glycopyrrolate
Active Ingredient
GlycopyrrolateCategory
Corticosteroid [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .2 mg/mL | INJECTION | INTRAMUSCULAR, INTRAVENOUS | 70700-264 |
Detailed information about Glycopyrrolate 1ml
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Glycopyrrolate 1ml, you must consult a qualified healthcare professional.
Glycopyrrolate is a potent muscarinic antagonist used to reduce excessive secretions in conditions like chronic sialorrhea and COPD, and as an adjunct for peptic ulcers. It belongs to the anticholinergic class of medications.
The dosage of glycopyrrolate must be individualized based on the condition being treated and the patient's response.
Glycopyrrolate is specifically approved for chronic drooling in pediatric patients.
Because glycopyrrolate is primarily excreted by the kidneys, patients with renal failure or significant impairment (GFR < 30 mL/min) require extreme caution. For oral use, doses should be significantly reduced, and the drug may be contraindicated in severe cases. For inhaled use, no specific adjustment is usually required for mild-to-moderate impairment, but monitoring is necessary for severe renal disease.
Since the liver plays a minor role in the metabolism of glycopyrrolate, no specific dosage adjustments are generally required for patients with liver disease. However, clinical monitoring for overall drug tolerance is always advised.
Elderly patients are more susceptible to the anticholinergic effects of glycopyrrolate, including urinary retention, constipation, and blurred vision. Healthcare providers typically start elderly patients at the lower end of the dosing range and monitor closely for cognitive changes or physical side effects.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to make up for a missed one, as this significantly increases the risk of toxicity.
An overdose of glycopyrrolate can lead to an 'anticholinergic crisis.' Symptoms include:
In the event of a suspected overdose, contact your local Poison Control Center or seek emergency medical attention immediately. Treatment often involves supportive care, and in severe cases, the administration of a cholinesterase inhibitor like physostigmine.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Because glycopyrrolate blocks acetylcholine throughout the body, side effects are common and generally reflect its anticholinergic nature. The most frequently reported adverse effects include:
> Warning: Stop taking Glycopyrrolate and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of glycopyrrolate, particularly for chronic drooling or hyperhidrosis, can lead to dental issues. Because saliva is necessary to neutralize mouth acids and wash away bacteria, chronic dry mouth (xerostomia) significantly increases the risk of dental caries (cavities), gingivitis, and oral thrush (candidiasis). Regular dental checkups and the use of fluoride rinses are often recommended for long-term users.
Additionally, chronic use in children requires monitoring for developmental and behavioral changes, although glycopyrrolate is generally considered safe for long-term use in the indicated pediatric populations when monitored by a specialist.
There are currently no FDA black box warnings for glycopyrrolate. However, the lack of a black box warning does not mean the drug is without risk; the potential for heatstroke and GI obstruction remains a primary clinical concern that requires diligent patient education.
Report any unusual symptoms to your healthcare provider. Your doctor may adjust your dose or suggest ways to manage side effects like dry mouth and constipation.
Glycopyrrolate is a potent medication that affects multiple organ systems. The most critical safety consideration is the risk of hyperthermia (heatstroke). Because the drug inhibits the eccrine sweat glands, patients lose their primary mechanism for thermoregulation. This is especially dangerous for children, the elderly, and those exercising in hot climates. Patients should be advised to avoid strenuous activity in the heat and to stay hydrated.
No FDA black box warnings for Glycopyrrolate. It is considered a well-established medication with a known safety profile when used according to labeling instructions.
Patients on long-term glycopyrrolate therapy should undergo periodic evaluations, including:
Glycopyrrolate may cause blurred vision or drowsiness in some individuals. Patients should not drive, operate heavy machinery, or engage in hazardous activities until they are certain the medication does not impair their vision or mental alertness.
While there is no direct chemical interaction between glycopyrrolate and alcohol, alcohol can worsen the dehydration and dizziness associated with anticholinergic drugs. Furthermore, alcohol can increase gastric acid production, potentially counteracting the benefits of glycopyrrolate when used for peptic ulcers. It is generally advised to limit alcohol consumption while on this medication.
Glycopyrrolate does not typically require a tapering schedule because it does not cause physiological dependence or a traditional withdrawal syndrome. However, stopping the drug suddenly will likely result in a rapid return of symptoms (e.g., a sudden increase in drooling or gastric acid). Always consult your doctor before stopping the medication to discuss alternative management strategies.
> Important: Discuss all your medical conditions with your healthcare provider before starting Glycopyrrolate, especially if you have a history of glaucoma, kidney disease, or heart problems.
Glycopyrrolate is not known to significantly interfere with common laboratory blood tests. However, it can affect the results of gastric acid secretion tests (by suppressing acid) and may interfere with skin allergy tests by reducing the inflammatory response. It may also affect the results of radionuclide gastric emptying studies.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is the best way to prevent dangerous interactions.
There are several conditions where the use of glycopyrrolate is strictly prohibited because the risks of therapy far outweigh any potential benefits:
These conditions require a careful 'risk vs. benefit' analysis by a healthcare professional:
Patients who have had a severe allergic reaction to other anticholinergic medications (such as atropine, hyoscyamine, or benztropine) should use glycopyrrolate with extreme caution, as there is a risk of cross-sensitivity. While the chemical structures differ slightly, the biological targets are the same, and similar hypersensitivity reactions may occur.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Glycopyrrolate. Ensure you disclose all past surgeries and chronic conditions.
Glycopyrrolate is generally classified as Pregnancy Category B (under the older FDA system). This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
It is not known whether glycopyrrolate is excreted in human milk. However, most anticholinergic drugs have the potential to suppress lactation (reduce the supply of breast milk). Because the drug is poorly absorbed orally, the risk of the infant receiving a significant dose through milk is low, but the risk of reduced milk production for the mother is high. Nursing mothers should discuss this with their pediatrician.
Glycopyrrolate is widely used and FDA-approved for children as young as 3 years old for the treatment of chronic severe sialorrhea.
Elderly patients (65 and older) are at a significantly higher risk for adverse effects.
Renal clearance is the primary pathway for glycopyrrolate elimination.
No dosage adjustments are typically required for patients with Child-Pugh Class A, B, or C hepatic impairment. However, clinicians should remain vigilant for signs of drug accumulation if the patient also has secondary renal issues (hepatorenal syndrome).
> Important: Special populations require individualized medical assessment. Never share your medication with others, especially those in these sensitive groups.
Glycopyrrolate is a competitive antagonist at muscarinic acetylcholine receptors. It has a high affinity for the M3 receptor (found in smooth muscle, exocrine glands, and vascular endothelium) and the M2 receptor (found in the heart). By binding to these receptors, it prevents the neurotransmitter acetylcholine from initiating the G-protein coupled signaling cascade that leads to cellular responses like muscle contraction or gland secretion. Its quaternary ammonium structure (a nitrogen atom with four organic groups attached) gives it a permanent positive charge, which prevents it from easily diffusing across the lipid-rich blood-brain barrier.
| Parameter | Value |
|---|---|
| Bioavailability | 3% - 10% (Oral) |
| Protein Binding | 38% - 44% |
| Half-life | 1.2 - 2.0 hours (IV); ~3 hours (Oral) |
| Tmax | 3 - 5 hours (Oral) |
| Metabolism | Minimal hepatic (CYP2D6) |
| Excretion | Renal (60-85% unchanged) |
Glycopyrrolate is classified as an Anticholinergic, Antimuscarinic, Quaternary Ammonium compound. It is therapeutically grouped with medications like methscopolamine and propantheline, but it is more commonly used in modern practice due to its predictable PK/PD profile. In the respiratory field, it is known as a Long-Acting Muscarinic Antagonist (LAMA).
Common questions about Glycopyrrolate 1ml
Glycopyrrolate is primarily used to reduce excessive secretions in various medical conditions. It is FDA-approved to treat chronic severe drooling (sialorrhea) in children with neurological disorders like cerebral palsy and as an adjunctive treatment for peptic ulcers in adults. In hospital settings, it is used during anesthesia to dry up respiratory secretions and protect the heart rate. It is also used in inhaled forms for the maintenance treatment of COPD. Some doctors prescribe it off-label to help manage excessive sweating, known as hyperhidrosis.
The most common side effect is dry mouth (xerostomia), which affects nearly everyone taking the medication. Other frequent side effects include constipation, blurred vision, and a dry or stuffy nose. Patients may also experience flushing of the skin and a slight increase in heart rate. Because it reduces sweating, many people feel more sensitive to heat while taking it. These effects are usually manageable but should be discussed with a healthcare provider if they become severe.
It is generally recommended to avoid or strictly limit alcohol while taking glycopyrrolate. Alcohol can increase the risk of dizziness and dehydration, which are already potential issues with anticholinergic drugs. Additionally, alcohol can stimulate stomach acid production, which may counteract the drug's effectiveness if you are taking it for a peptic ulcer. Combining the two may also increase the likelihood of feeling overheated. Always consult your doctor for personalized advice regarding alcohol consumption.
Glycopyrrolate is considered a Pregnancy Category B medication, meaning animal studies haven't shown a risk, but human data is limited. Because it is a quaternary ammonium compound, it does not cross the placenta easily, which makes it theoretically safer for the fetus than some other medications. However, it should only be used if the potential benefits clearly outweigh the risks to the mother and baby. Your obstetrician will help determine if it is the safest choice for your specific situation. Always inform your doctor if you are pregnant or planning to become pregnant.
The onset of action depends on how the medication is administered. If taken as an oral tablet or solution, it typically starts working within 45 to 60 minutes, with peak effects occurring 3 to 5 hours after the dose. When given as an injection in a clinical setting, the effects are much faster, often appearing within one minute. For the inhaled version used for COPD, some bronchodilation occurs quickly, but it is meant for long-term maintenance rather than immediate rescue. Consistency is key for chronic conditions like drooling.
You can generally stop taking glycopyrrolate without experiencing a dangerous withdrawal syndrome, as it is not addictive. However, stopping the drug suddenly will likely cause your symptoms—such as excessive drooling or stomach acid—to return immediately. If you are taking it for a chronic condition, it is best to talk to your doctor before stopping. They may want to monitor your symptoms or suggest a different treatment plan. Never stop a prescribed medication without medical consultation.
If you miss a dose, you should take it as soon as you remember, provided it isn't almost time for your next dose. If your next dose is only a few hours away, skip the missed dose and resume your regular schedule. You should never take two doses at once to make up for a missed one. Taking too much glycopyrrolate at once can lead to toxicity, including severe blurred vision and an inability to urinate. Setting a daily alarm can help you stay on track with your medication.
Weight gain is not a recognized or common side effect of glycopyrrolate. The drug works on the parasympathetic nervous system to reduce secretions and does not typically affect metabolism, appetite, or fat storage. If you notice significant weight changes while taking this medication, it may be due to other factors or a different medication you are taking. You should discuss any unexpected weight changes with your healthcare provider to find the underlying cause. Staying active and eating a balanced diet remains important.
Glycopyrrolate can interact with several other drugs, so caution is necessary. It should not be taken with solid potassium tablets, as it can cause intestinal ulcers, or with other strong anticholinergic drugs like certain antihistamines. It may also affect how your body absorbs drugs like digoxin. Because it slows down the digestive system, it can change the timing of how other oral medicines enter your bloodstream. Always provide your doctor with a full list of your current medications and supplements.
Yes, glycopyrrolate is available as a generic medication in both tablet and injectable forms. The oral solution is also available as a generic, though it may still be sold under the brand name Cuvposa. Generic versions are typically much more affordable than brand-name drugs and are required by the FDA to have the same active ingredient and efficacy. Check with your pharmacist to see if a generic version is available for your specific prescription. Most insurance plans cover the generic form.
Other drugs with the same active ingredient (Glycopyrrolate)